Clinical Trial Update: Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety of a second dose of tenecteplase in acute ischemic stroke patients who did not respond to the first dose; No…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Memorial Hermann Health System | Conditions: Acute Ischemic Stroke | Phase 1 | Status: NOT_YET_RECRUITING